SCHEMBL21357413

SCHEMBL21357413

N[C@]1(Cc2ccccc2)C=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC29A1 Q99808 2/20 0.40
▸ SLC28A1 O00337 1/20 0.40
▸ SLC28A2 O43868 1/20 0.40
▸ SLC28A3 Q9HAS3 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ THRB P10828 1/20 0.38
▸ MTOR P42345 1/20 0.38
▸ MDM2 Q00987 1/20 0.38
▸ NCOA1 Q15788 1/20 0.38
▸ NCOA3 Q9Y6Q9 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CDA P32320 4/20 0.38
▸ MAPT P10636 1/20 0.38
▸ PYGM P11217 1/20 0.38
▸ P2RY2 P41231 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4751008 0.83 LMNA (0.42) SLC29A1SLC28A1SLC28A2SLC28A3LMNA
SCHEMBL10903331 0.83 LMNA (0.42) SLC29A1SLC28A1SLC28A2SLC28A3LMNA
SCHEMBL9213688 0.81 SLC29A1 (0.44) SLC29A1SLC28A1SLC28A2SLC28A3MEN1
SCHEMBL28159962 0.80 LMNA (0.40) SLC29A1SLC28A1SLC28A2SLC28A3MEN1
SCHEMBL6906558 0.80 LMNA (0.45) SLC29A1SLC28A1SLC28A2SLC28A3LMNA
SCHEMBL3630509 0.80 LMNA (0.45) SLC29A1SLC28A1SLC28A2SLC28A3LMNA
SCHEMBL27284021 0.80 SLC28A1 (0.39) SLC29A1SLC28A1SLC28A2SLC28A3LMNA
SCHEMBL25188377 0.79 CDA (0.43) SLC29A1SLC28A1SLC28A2SLC28A3LMNA
SCHEMBL10903345 0.78 CDA (0.42) SLC29A1SLC28A1SLC28A2SLC28A3LMNA
SCHEMBL31436719 0.78 CDA (0.42) SLC29A1SLC28A1SLC28A2SLC28A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198958-A1 NUCLEIC ACID POLYMERS Janssen Biopharma, Inc. (US) 2021-10-07 — — WO disclosed
EP-3765476-A2 MODIFIED OLIGONUCLEOTIDES FOR USE IN TREATMENT OF TAUOPATHIES Janssen Pharmaceutica NV (BE) 2021-01-20 — — EP disclosed
WO-2019175260-A2 MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE IN TAUOPATHIES JANSSEN PHARMACEUTICA NV (BE) 2019-09-19 — — WO disclosed
Send feedback